在心力衰竭中减少喷射分数的脏保护:不是所有闪闪发光的都是黄金
Elisa Russo1, Emilio Venturelli2, Giovanna Leoncini1
1Department of Internal Medicine, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
European journal of internal medicine
|December 17, 2025
概括
慢性病 (CKD) 常见于心力衰竭与减少喷射率 (HFrEF). 像RNAI和SGLT2抑制剂这样的新疗法提供了显著的心脏脏保护,改善了这些高风险患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性病 (CKD) 影响40-60%的慢性心力衰竭患者减少排气分数 (HFrEF).
- 像高血压和糖尿病这样的共同危险因素加剧了这两种情况.
- 降低功能会使HFrEF结果恶化,并使治疗复杂化.
研究的目的:
- 审查对HFrEF患者中CKD管理的药理学策略的证据.
- 为优化心脏和脏结局提供最新的视角.
主要方法:
- 随机对照试验的叙述审查.
- 专注于在HFrEF中影响脏结果的治疗课程.
主要成果:
- 已建立的疗法 (RAAS 抑制剂,β 抑制剂) 改善了生存率.
- 矿物质皮质类受体抗剂 (MRAs) 提供心脏和脏的保护.
- RNAI和SGLT2抑制剂显示出显著的心脏脏益处,无论糖尿病或CKD阶段.
结论:
- 药理学的进步已经显著改善了HFrEF中的心脏结局.
- SGLT2 抑制剂代表了HFrEF中脏保护的关键治疗进展.
- 优化医疗管理对于改善CKD和HFrEF患者的预后至关重要.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
879
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
879
Heart Failure Drugs: Diuretics
764
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
764
Heart Failure V: Medical Management
198
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
Acute Kidney Injury IV: Diagnostic Studies and Prevention
243
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
243
Renal Failure: Dose Adjustments
404
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
404
Heart Failure II: Pathophysiology
668
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
668


